Search

Blog Post

Could psychedelic drugs relieve cancer pain?

… called micro-dosing.” He adds that the clinical trial will mark the first time micro-dosing has been used to study how … therapist, and Dr. Case is about to begin a year-long psychedelic-assisted psychotherapy training program as … called micro-dosing.” He adds that the clinical trial will mark the first time micro-dosing has been used to study how …
Page with Layout

Current Residents & Alumni

… We want your affiliation with Roswell Park to extend long beyond your time here, so we created the Alumni of … Ohio State University Comprehensive Cancer Center  2022 — Mark Farrugia, MD, PhD , is an Assistant Professor at Roswell …
News

Survey Shows Majority of Americans Unaware Of Innovative Cancer Treatment

… surgery, offering patients new hope for the possibility of long-term remission.  However, a new survey by Roswell Park … States. It contains 20 sterile rooms across two buildings, marking a transformative step for cancer research and … surgery, offering patients new hope for the possibility of long-term remission.  However, a new survey by Roswell Park …
Blog Post

Can Roswell Park’s promising brain cancer vaccine work for children and young adults?

… times over six weeks, and then once every three months as long as it continues to be effective. Blood tests performed … safety. Looking ahead toward the next breakthrough This marks the beginning of what promises to be an epic journey, … times over six weeks, and then once every three months as long as it continues to be effective. Blood tests performed …
Blog Post

How lung cancer screening saved Tina's life

… This quick, easy and pain-free test detects early cancers long before any symptoms appear. When Tina Morgan, age 63, … she had an appointment with Roswell Park thoracic surgeon Mark Hennon, MD, FACS , Associate Professor of Oncology and … she had an appointment with Roswell Park thoracic surgeon Mark Hennon, MD, FACS , Associate Professor of Oncology and …
Blog Post

Delivering on the promise of ‘living drugs’

… this,” says Dr. Brentjens. “About 40% of patients achieve long-term remission or cure.”  Recognized as a pioneer in the … combat solid tumors more effectively.  The clinical trial marks the first time patients’ T cells will be manufactured … this,” says Dr. Brentjens. “About 40% of patients achieve long-term remission or cure.”  Recognized as a pioneer in the …

Department of Pharmacology & Therapeutics

… Dr. Tang Selected recent publications Kirk JS, Wang J, Long M, Rosario S, Tracz A, Ji Y, Kumar R, Liu X, Jamroze A, … M , Goodrich Z, Goodrich M, Labbe D, Gomez E, Wang J , Long H, Xu B , Brown M, Loda M, Sawyers C, Ellis L, Goodrich … Goodrich, Gurkamal Chatta, Dean Tang, Dominic Smiraglia, Mark Long Meet Dr. Goodrich Goodrich Lab Spotlight: …